Pancreatic Cancer Research

ResearcherUniversity of OxfordActive in the last 2 years

Chao‐Hui Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1401-2403; OpenAlex author ID A5027257973. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 5

  1. GluProRS Inhibition Abolishes Cancer Stem Cells in Pancreatic Cancer by Inducing the Integrated Stress Response and Countering TGFβ/Activin-SMAD2/3-HIF1A Co-author DOI 10.21203/rs.3.rs-6672561/v1↗
  2. BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.09.021↗
  3. Quantitative secretomics identifies ligand-receptor pairs in pancreatic cancer that mediate bidirectional crosstalk between cancer stem cells and nociceptors Co-author DOI 10.21203/rs.3.rs-3994602/v1↗
  4. Extracellular vesicles in pancreatic cancer progression and therapies. Co-author DOI 10.1038/s41419-021-04258-7↗
  5. Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells. First author DOI 10.1016/j.tips.2020.09.008↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Siim Pauklin · 5 shared papers, 2020–2025 · strength 1.04
  2. Stefania Militi · 3 shared papers, 2024–2025 · strength 0.58
  3. Andrei-Florian Stoica · 1 shared paper, 2020 · strength 0.19
  4. Yuliang Feng · 1 shared paper, 2024 · strength 0.15
  5. Mai Abdel Mouti · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.